Update on Office-Based Strategies for the Management of Obesity

Ghaffar, Oms-Iv Atif; Bindra, Oms-Ii Sumrita; Persits, Oms-Iv Ian; Geris, DO Shady; Levy, Oms-Iii Sara; Villanueva, DO Jose; Happel, DO Patricia; Donoghue, Joanne; Yao, DO Sheldon C.

doi:10.33181/12043

Cited by 2 publications

(11 citation statements)

References 45 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To establish which medications should not be prescribed for the treatment of patients with obesity, experts state that the following medications are not considered anti-obesity and therefore should not be prescribed for weight loss purposes (LE: B; R: III): 18,83,88,90,115,116 • thyroid hormones;…”

Section: Non-recommended Therapiesmentioning

confidence: 99%

“…Treatment success should be defined as achievement of the following goals (LE: A; R: I): 16,83,85 sustained weight loss of 5%–10% over time; permanent lifestyle changes; improvement or prevention of comorbidities; and improved quality of life. In responders, medications improve weight loss and enhance the management of concomitant metabolic diseases. A responder or rapid responder patient is defined as a patient that loses 5% or more of their initial weight after 12 weeks of treatment at optimal medication doses 104 …”

Section: Consensus Statementmentioning

confidence: 99%

“…There is a list of drugs used in the treatment of various chronic diseases that result in weight gain and optional pharmacological choices (Table 8). 18,83,84,130–132 …”

Section: Consensus Statementmentioning

confidence: 99%

“…Pharmacological treatment is indicated in patients with a BMI of ≥30 or ≥27 kg/m 2 with at least one comorbidity when lifestyle changes are insufficient to achieve weight loss objectives or maintain those goals (LE: A; R: I). [15][16][17][18][19][20][21][22][83][84][85][86][87][88][89][90][91] The clinical and anthropometric parameters for prescribing pharmacological therapy are (LE: A; R: I) [83][84][85][86][87][88][89][90][91][92][93][94][95] • age;…”

Section: Indicationsmentioning

confidence: 99%

“…Treatment success should be defined as achievement of the following goals (LE: A; R: I): 16,83,85 • sustained weight loss of 5%-10% over time;…”

Section: Treatment Successmentioning

confidence: 99%

See 4 more Smart Citations

Consensus on pharmacological treatment of obesity in Latin America

Cappelletti,

Valenzuela Montero,

Cercato

et al. 2023

Obesity Reviews

View full text Add to dashboard Cite

SummaryA panel of 10 experts in obesity from various Latin American countries held a Zoom meeting intending to reach a consensus on the use of anti‐obesity medicines and make updated recommendations suitable for the Latin American population based on the available evidence. A questionnaire with 16 questions was developed using the Patient, Intervention, Comparison, Outcome (Result) methodology, which was iterated according to the modified Delphi methodology, and a consensus was reached with 80% or higher agreement. Failure to reach a consensus led to a second round of analysis with a rephrased question and the same rules for agreement. The recommendations were drafted based on the guidelines of the American College of Cardiology Foundation/American Heart Association Task Force on Practice. This panel of experts recommends drug therapy in patients with a body mass index of ≥30 or ≥27 kg/m2 plus at least one comorbidity, when lifestyle changes are not enough to achieve the weight loss objective; alternatively, lifestyle changes could be maintained while considering individual parameters. Algorithms for the use of long‐term medications are suggested based on drugs that increase or decrease body weight, results, contraindications, and medications that are not recommended. The authors concluded that anti‐obesity treatments should be individualized and multidisciplinary.

show abstract

Section: Non-recommended Therapiesmentioning

confidence: 99%

Section: Consensus Statementmentioning

confidence: 99%

“…There is a list of drugs used in the treatment of various chronic diseases that result in weight gain and optional pharmacological choices (Table 8). 18,83,84,130–132 …”

Section: Consensus Statementmentioning

confidence: 99%

Section: Indicationsmentioning

confidence: 99%

“…Treatment success should be defined as achievement of the following goals (LE: A; R: I): 16,83,85 • sustained weight loss of 5%-10% over time;…”

Section: Treatment Successmentioning

confidence: 99%

See 3 more Smart Citations

Consensus on pharmacological treatment of obesity in Latin America

Cappelletti,

Valenzuela Montero,

Cercato

et al. 2023

Obesity Reviews

View full text Add to dashboard Cite

show abstract

Factors Influencing Referral for Bariatric Surgery by Primary Care Physicians in Northern Israel

Zoabi,

Elran-Barak,

Sakran

et al. 2024

OBES SURG

View full text Add to dashboard Cite

Purpose Obesity is a chronic metabolic disease with global distribution among adults and children which affects daily functioning and ultimately quality of life. Primary care physicians (PCPs) provide an important role for the treatment of severe obesity. Better understanding of obesity and its treatment options may increase patients’ referral rates to the various treatment modalities, including metabolic/bariatric surgery (MBS). Materials and Methods A quantitative cross-sectional study used a self-reported questionnaire among PCPs of Clalit Health Services (CHS) in Northern Israel. The quantitative questionnaire examined the PCP’s knowledge, opinions, attitude, and approaches to managing severe obesity. Results A total of 246 PCPs from Northern Israel filled the questionnaire (42.9%), the majority were Muslim Arabs (54.5%), who gained their medical degree outside of Israel (73.8%) and practicing for over 10 years (58.8%). 64.3% of PCPs had a high workload (over 100 appointments per week), 77.1% did not know the definition of severe obesity, and 69.17% did not attend educational meetings regarding obesity during the previous year. The referral rate for MBS was 50.4% ± 23.3. Two prognostic factors that had a statistically significant effect on the referral rate for bariatric surgery were the total appointments per week, and the number of practice years. Both had a negative association. Conclusion The knowledge and referral rates for bariatric surgery are higher among PCPs with lower workload and relatively fewer practice years. Workshops and annual training courses may fortify knowledge and awareness for the treatment of obesity, which in turn could increase the referral rate for MBS.

show abstract

Update on Office-Based Strategies for the Management of Obesity

Cited by 2 publications

References 45 publications

Consensus on pharmacological treatment of obesity in Latin America

Consensus on pharmacological treatment of obesity in Latin America

Factors Influencing Referral for Bariatric Surgery by Primary Care Physicians in Northern Israel

Contact Info

Product

Resources

About